Autoimmune response to advanced glycosylation end-products of human LDL

Autoimmune response to advanced glycosylation end-products of human LDL

Advanced glycosylation end-products (AGEs) are believed to play a significant role in the development of vascular complications in diabetic patients. One such product, AGE-LDL, has been shown to be immunogenic. In this report, we describe the isolation and characterization of human AGE-LDL antibodie...

Full description

Bibliographic Details
Main Authors:	Gabriel Virella, Suzanne R. Thorpe, Nathan L. Alderson, Elias M. Stephan, Daniel Atchley, Francesco Wagner, Maria F. Lopes-Virella
Format:	Article
Language:	English
Published:	Elsevier 2003-03-01
Series:	Journal of Lipid Research
Subjects:	modified lipoproteins diabetes immunogenicity of advanced glycosylation end-products-LDL advanced glycosylation end-products-LDL antibodies
Online Access:	http://www.sciencedirect.com/science/article/pii/S002222752031186X

Similar Items

Comparative Analysis of Serum Levels of Total Carbohydrates and Protein Linked Carbohydrates in Normal and Diabetic Individuals
by: Praveen Sablania, et al.
Published: (2019-05-01)

Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus
by: Kathryn C.B. Tan, et al.
Published: (2008-07-01)

Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers
by: Elena Dozio, et al.
Published: (2021-10-01)

AGER-1 Long Non-Coding RNA Levels Correlate with the Expression of the Advanced Glycosylation End-Product Receptor, a Regulator of the Inflammatory Response in Visceral Adipose Tissue of Women with Obesity and Type 2 Diabetes Mellitus
by: Klaudia Gutowska, et al.
Published: (2023-12-01)

Role Played by Receptors for Advanced Glycosylation End Products in Corneal Endothelial Cells after HSV-1 Infection
by: Dai Miyazaki, et al.
Published: (2021-05-01)

Assessment of Myo‌inositol and Crocin Effects on RAGE and TGF? Gene Expression in the Kidney of Streptozotocin Induced Diabetic Rats
by: Somayeh Sadat Heidary, et al.
Published: (2014-09-01)

ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury
by: Shengqi Huo, et al.
Published: (2023-01-01)

Weak Association between Skin Autofluorescence Levels and Prediabetes with an ILERVAS Cross-Sectional Study
by: Enric Sánchez, et al.
Published: (2022-03-01)

Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases
by: Eun Ji Lee, et al.
Published: (2013-12-01)

Chemical modification of proteins during peroxidation of phospholipids
by: Andrzej S. Januszewski, et al.
Published: (2005-07-01)

High Glucose and Advanced Glycation End Products Induce CD147-Mediated MMP Activity in Human Adipocytes
by: Abeer M. Mahmoud, et al.
Published: (2021-08-01)

Could AGEs be markers of pre-eclampsia? Study of concentration of advanced protein glycation products in pregnant women with physiological pregnancy and pregnancy complicated with pre-eclampsia
by: Piotr Bodzek, et al.
Published: (2022-10-01)

Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review
by: Austin Nguyen, et al.
Published: (2016-04-01)

Density distribution of electronegative LDL in normolipemic and hyperlipemic subjects
by: José Luis Sánchez-Quesada, et al.
Published: (2002-05-01)

LDLCHOLESTEROLEXAMINATION (LDL-C) USINGHOMOGENEOUS ASSAY
by: Made DwiAmbara Putra
Published: (2013-07-01)

Autocatalytic cycle in the pathogenesis of diabetes mellitus: biochemical and pathophysiological aspects of metabolic therapy with natural amino acids on the example of glycine
by: Semen V. Nesterov, et al.
Published: (2018-09-01)

Diabetic conditions modulate the adenosine monophosphate-activated protein kinase of podocytes
by: Tae-Sun Ha, et al.
Published: (2014-03-01)

Protective effect of pyridoxamine on RPE cells treated with AGEs
by: Min Zhou, et al.
Published: (2018-10-01)

Modulation of cell proliferation, survival and gene expression by RAGE and TLR signaling in cells of the innate and adaptive immune response: role of p38 MAPK and NF-KB
by: Marcell Costa de MEDEIROS, et al.
Published: (2014-06-01)

Targeting advanced glycation end products in cardiac surgery: The unexplored alternative
by: Antonio Nenna, et al.
Published: (2016-01-01)

Allicin alleviates the decline in the learning ability and neuronal apoptosis in hippocampus of OSAHS model rats
by: WANG Chao, GENG Cai-hong, ZHAO Kun-peng, JI Peng
Published: (2022-10-01)

Effects of Exogenous Dietary Advanced Glycation End Products on the Cross-Talk Mechanisms Linking Microbiota to Metabolic Inflammation
by: Raffaella Mastrocola, et al.
Published: (2020-08-01)

Advanced glycation end-products (AGEs) accumulation in skin: relations with chronic kidney disease-mineral and bone disorder
by: Renata de Almeida França, et al.
Published: (2017-08-01)

Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles
by: Antonio J. Amor, et al.
Published: (2020-08-01)

Can Electronegative LDL Act as a Multienzymatic Complex?
by: Sonia Benitez, et al.
Published: (2023-04-01)

The Role of Advanced Glycation End Products in Diabetic Vascular Complications
by: Sang Youl Rhee, et al.
Published: (2018-05-01)

Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)
by: Tina Z. Khan, et al.
Published: (2021-01-01)

Advanced Glycation End Products Downregulate Connexin 43 and Connexin 40 in Diabetic Atrial Myocytes via the AMPK Pathway
by: Yang F, et al.
Published: (2023-10-01)

Effects of cheerleading practice on advanced glycation end products, areal bone mineral density, and physical fitness in female adolescents
by: Lijun Wang, et al.
Published: (2022-09-01)

The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus
by: Isabella Bonilha, et al.
Published: (2021-11-01)

Uremic Advanced Glycation End Products and Protein‐Bound Solutes Induce Endothelial Dysfunction Through Suppression of Krüppel‐Like Factor 2
by: Keith Saum, et al.
Published: (2018-01-01)

Effect of Different High-Fat and Advanced Glycation End-Products Diets in Obesity and Diabetes-Prone C57BL/6 Mice on Sperm Function
by: Fahimeh Akbarian, et al.
Published: (2021-07-01)

Insulin resistance and generation of advanced glycation end products
by: Alvaro Gudiño Gomezjurado, et al.
Published: (2013-04-01)

Simultaneous Electrochemical Detection of LDL and MDA-LDL Using Antibody-Ferrocene or Anthraquinone Conjugates Coated Magnetic Beads
by: Daria Rudewicz-Kowalczyk, et al.
Published: (2023-03-01)

Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia
by: B.M. Schamberger, et al.
Published: (2000-05-01)

Non-apoptotic programmed cell deaths in diabetic pulmonary dysfunction: the new side of advanced glycation end products
by: Yimin Dai, et al.
Published: (2023-10-01)

Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies
by: Gabriel Virella, et al.
Published: (2004-10-01)

The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial
by: Adam Hartley, et al.
Published: (2021-10-01)

Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
by: Misganaw Asmamaw Mengstie, et al.
Published: (2022-09-01)

Correlation between the accumulation of skin glycosylation end products and the development of type 2 diabetic peripheral neuropathy
by: Xing-Wang Zhao, et al.
Published: (2022-04-01)